Peripheral cytokine interleukin‐10 alleviates perihematomal edema after intracerebral hemorrhage via interleukin‐10 receptor/ JAK1 / STAT3 signaling
CNS Neuroscience & Therapeutics · 2024-06 · 30 (6)
DOI: 10.1111/cns.14796 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 12.06.2024. Verfasst von Yao Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and State Key Laboratory of Trauma and Chemical Poisoning, Southwest Hospital, Third Military Medical University (Army Med…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Cerebral Hemorrhage, Brain Edema, Janus Kinase 1. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science-Health Joint Medical Scientific Research Project of Chongqing, National Natural Science Foundation of China, Chongqing Talents Project.
Abstract (Originalsprache)
Aims
The extent of perihematomal edema following intracerebral hemorrhage (ICH) significantly impacts patient prognosis, and disruption of the blood–brain barrier (BBB) exacerbates perihematomal edema. However, the role of peripheral IL‐10 in mitigating BBB disruption through pathways that link peripheral and central nervous system signals remains poorly understood.
Methods
Recombinant IL‐10 was administered to ICH model mice via caudal vein injection, an IL‐10‐inhibiting adeno‐associated virus and an IL‐10 receptor knockout plasmid were delivered intraventricularly, and neurobehavioral deficits, perihematomal edema, BBB disruption, and the expression of JAK1 and STAT3 were evaluated.
Results
Our study demonstrated that the peripheral cytokine IL‐10 mitigated BBB breakdown, perihematomal edema, and neurobehavioral deficits after ICH and that IL‐10 deficiency reversed these effects, likely through the IL‐10R/JAK1/STAT3 signaling pathway.
Conclusions
Peripheral IL‐10 has the potential to reduce BBB damage and perihematomal edema following ICH and improve patient prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery and State Key Laboratory of Trauma and Chemical Poisoning, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Chongqing Key Laboratory of Intelligent Diagnosis, Treatment and Rehabilitation of Central Nervous System Injuries, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Chongqing Clinical Research Center for Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Department of Neurosurgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Qin Hu, Yujie Chen
Förderung
- Science-Health Joint Medical Scientific Research Project of Chongqing
- National Natural Science Foundation of China
- Chongqing Talents Project
Zitieren
APA
Xu, Y., Wang, K., Dai, Y., Yang, W., Ru, X., Li, W., Feng, H., Zhu, G., Hu, Q., & Chen, Y. (2024). Peripheral cytokine interleukin‐10 alleviates perihematomal edema after intracerebral hemorrhage via interleukin‐10 receptor/ JAK1 / STAT3 signaling. CNS Neuroscience & Therapeutics, 30(6). https://doi.org/10.1111/cns.14796
Vancouver
Xu Y, Wang K, Dai Y, Yang W, Ru X, Li W, et al. Peripheral cytokine interleukin‐10 alleviates perihematomal edema after intracerebral hemorrhage via interleukin‐10 receptor/ JAK1 / STAT3 signaling. CNS Neuroscience & Therapeutics. 2024;30(6). doi:10.1111/cns.14796
BibTeX
@article{Xu2024,
author = {Xu, Yao and Wang, Kaishan and Dai, Yalan and Yang, Wei and Ru, Xufang and Li, Wenyan and Feng, Hua and Zhu, Gang and Hu, Qin and Chen, Yujie},
title = {Peripheral cytokine interleukin‐10 alleviates perihematomal edema after intracerebral hemorrhage via interleukin‐10 receptor/ JAK1 / STAT3 signaling},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {6},
doi = {10.1111/cns.14796}
}
EUVIMED